| ||||
---|---|---|---|---|
random sequence generation | random number generator | not described | random number generator | random number generator |
allocation concealment | central allocation | not described | central allocation | central allocation |
blinding of participants/personnel | no | no | no (only pathologists were blinded) | double-blinded (placebo-controlled) |
blinding of outcome assessment | unclear | unclear | unclear | unclear |
incomplete outcome data | low risk (a) | low risk (a) | low risk (a) | low risk (a) |
selective reporting | low risk (b) | high risk (c) | low risk (b) | low risk (b, d) |
note/other bias | randomization of 977 patients but only 173 (18%) presented with lymph node-positive disease. | staging was retrospectively regraded to ensure comparable groups; initially planned for 400 patients but stopped after inclusion of 91 of which only 39 patients (43%) presented with lymph node-positive disease. | staging was retrospectively regraded to ensure comparable groups; initially planned for 220 lymph node-positive patients but stopped after inclusion of 100 of which only 98 were randomized | randomization of 8113 patients but only 150 (2%) presented lymph node-positive disease (radical prostatectomy: 74 patients, radiotherapy: 14 patients, watchful waiting: 62 patients). |